Concepedia

Aurash Naser‐Tavakolian

AN

Statistics

Publications

6

Citations

235

H-Index

6

Active since

2013

Affiliations

University of Southern California(Current)

Cedars-Sinai Medical Center

Tokyo University of Pharmacy and Life Sciences

University of California San Diego

Durham VA Medical Center

Aurash Naser‐Tavakolian is an author at University of Southern California specializing in ligand-based design, drug discovery, and medicine.

ORCID

Publications per year

2013–2024

6

Publications

6

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies

Thanigaimalai Pillaiyar, Sho Konno, Takehito Yamamoto et al. · European Journal of Medicinal Chemistry · 2013 · 106 citations · Full text

, , +17

Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study

Thanigaimalai Pillaiyar, Sho Konno, Takehito Yamamoto et al. · European Journal of Medicinal Chemistry · 2013 · 69 citations · Full text

, , +16

Patient- and tumor-level risk factors for MRI-invisible prostate cancer

Paige Kuhlmann, Michelle Chen, Michael Luu et al. · Prostate Cancer and Prostatic Diseases · 2021 · 22 citations

, , +14

Internal audit of an enhanced recovery after surgery protocol for radical cystectomy

Saum Ghodoussipour, Aurash Naser‐Tavakolian, Brian Cameron et al. · World Journal of Urology · 2020 · 13 citations

, , +14

Variation in Communication of Competing Risks of Mortality in Prostate Cancer Treatment Consultations

Timothy J. Daskivich, Rebecca Gale, Michael Luu et al. · The Journal of Urology · 2022 · 13 citations · Full text

, , +17

1–5 of 6